Drawing for ELPHOGENE ONCOMONITOR

USPTO serial 79281796

ELPHOGENE ONCOMONITOR

Reviewed by CopyMark Law Group

Reg. 6235961Status 700Renewal
Filing date
Status date
Registration date
Jan 5, 2021
Examiner
ALTREE,NICHOLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELPHOGENE ONCOMONITOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

John Alumit ALUMIT IP135 S. Jackson Street, Suite 200Glendale, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; laboratory apparatus for analysis and diagnosis carried out on cells; downloadable computer software for processing and synthesizing images of cells and tissues in the field of diagnosis and research; scientific research apparatus and instruments for laboratories, namely, ultra-high vacuum chambers; diagnostic apparatus, not for medical purposes, for the detection of pathogens for laboratory or research use; laboratory chemical reactors; chemistry apparatus and instruments for measuring chemical concentrations in water; measuring apparatus and instrumentation, namely, digitizers for use in the fields of biochemistry and analytical chemistry; apparatus for testing gas, liquids and solids for use in the fields of biochemistry and analytical chemistry; apparatus for the transmission of data; electrical monitoring apparatus, namely, wireless controllers for monitoring and controlling the functioning of other electronic devices for use in the fields of biochemistry and analytical chemistry; prerecorded magnetic data carriers featuring scientific research data; downloadable software, namely, computer operating programs; recorded computer programs in the field of data processing, namely, database management software; computer hardware and downloadable software for use in database management, data storage, processing and analysis in the fields of healthcare, biochemistry and analytical chemistry; computer hardware and downloadable computer software for use in controlling scientific apparatus; downloadable software for processing, categorization and analysis of laboratory testing data; blank digital storage media for storing audio files, image files, text files or other data or information; electronic databases in the field of biochemistry and analytical chemistry recorded on computer media; interactive computer hardware and recorded software systems for laboratory instrument programming and control; data processors; downloadable electronic publications, namely, magazines, newsletters, and books in the fields of biochemistry and analytical chemistry; electronic publications recorded on computer media, namely, magazines, newsletters, books in the fields of biochemistry and analytical chemistry; downloadable electronic magazines in the fields of biochemistry and analytical chemistry; downloadable e-books in the field of biochemistry and analytical chemistry; computer hardware and downloadable software for use in downloading, storing and displaying electronic periodicals, books and magazinesACTIVE—
010medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus for use in cellular analysis and diagnosis, namely, cell culture chambers; medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for detecting cancer; ultrasonic medical diagnostic apparatus; surgical apparatus and instruments; blood and body fluid analyzers for medical diagnostic use; robotics for medical purposes, namely, surgical robots; medical apparatus for measuring and displaying data measured from bodily fluids, and parts therefor; blood testing apparatus; medical apparatus for measuring biochemical changes in the blood; medical devices for measuring biomarkers in the bloodACTIVE—
044medical diagnostic testing, monitoring and reporting services; medical services in the field of oncology and outpatient oncology; genetic testing for medical purposes; performing diagnosis of diseases; health screening in the field of oncology and genetic testing; providing medical information in the form of reports in the field of oncology and genetic testing; health assessment services conducted through the use of health assessment surveys; medical advisory services; providing on-line medical information relating to oncology; providing news and information in the field of medicine; medical treatment analysis provided by medical laboratories; medical laboratory services for the medical analysis of samples taken from patients; health advice and information services; medical information services provided via the internetACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 5, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 2, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 10, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 10, 2021FIMPFINAL DISPOSITION PROCESSED—
Apr 5, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 6, 2020GPNXNOTIFICATION PROCESSED BY IB—
Nov 17, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 20, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 30, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Sep 14, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 14, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 14, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 14, 2020CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 12, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 15, 2020RFNTREFUSAL PROCESSED BY IB—
Apr 25, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 25, 2020RFRRREFUSAL PROCESSED BY MPU—
Apr 11, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 10, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 31, 2020DOCKASSIGNED TO EXAMINER—
Mar 31, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance